Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,557 | -12,838 | N/A | N/A | N/A |
| Depreciation Amortization | 620 | 670 | N/A | N/A | N/A |
| Accounts receivable | 253 | 549 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,779 | 3,485 | N/A | N/A | N/A |
| Other Working Capital | -5,173 | -9,842 | N/A | N/A | N/A |
| Other Operating Activity | -11,186 | -6,487 | 0 | 0 | 0 |
| Operating Cash Flow | $-48,265 | $-24,463 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,154 | -538 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,154 | $-538 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 126,739 | 63,683 | N/A | N/A | N/A |
| Other Financing Activity | -9,323 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $117,416 | $63,683 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 9,155 | 2,177 | N/A | N/A | N/A |
| Beginning Cash Position | 55,705 | 25,828 | N/A | N/A | N/A |
| End Cash Position | 132,858 | 66,687 | N/A | N/A | N/A |
| Net Cash Flow | $77,153 | $40,859 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,265 | -24,463 | N/A | N/A | N/A |
| Capital Expenditure | -1,154 | -538 | N/A | N/A | N/A |
| Free Cash Flow | -49,418 | -25,002 | 0 | 0 | 0 |